Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Fate Therapeutics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- −45 vs. Q4 2022
- Shares held
- 112.5M
- +6.95M (+6.6%) vs. Q4 2022
- Total value
- $641.6M
- −$423.2M (−39.7%) vs. Q4 2022
- New holders
- 21
- 73 more added
- Sold out
- 66
- 55 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $193.2M |
| Q1 2026 | 158 | $88.9M |
| Q4 2025 | 146 | $70.9M |
| Q3 2025 | 143 | $101.6M |
| Q2 2025 | 139 | $88.9M |
| Q1 2025 | 132 | $76.3M |
| Q4 2024 | 159 | $166.5M |
| Q3 2024 | 164 | $401.6M |
| Q2 2024 | 182 | $401.1M |
| Q1 2024 | 167 | $904.0M |
| Q4 2023 | 159 | $357.2M |
| Q3 2023 | 171 | $202.9M |
| Q2 2023 | 188 | $519.6M |
| Q1 2023 | 182 | $641.6M |
| Q4 2022 | 228 | $1.07B |
| Q3 2022 | 239 | $2.41B |
| Q2 2022 | 233 | $2.70B |
| Q1 2022 | 249 | $3.92B |
| Q4 2021 | 250 | $5.66B |
| Q3 2021 | 266 | $5.67B |
| Q2 2021 | 272 | $8.20B |
| Q1 2021 | 260 | $7.73B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Segall Bryant & Hamill, LLC | 0 | $0 | 0.00% | −164,235−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −158,802−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −151,152−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −139,000−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −137,341−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −118,540−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −104,653−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −102,094−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −89,403−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −86,500−100.0% | Sold out |
| Epiq Partners, LLC | 0 | $0 | 0.00% | −71,521−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −51,754−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −51,574−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −51,331−100.0% | Sold out |
| Echo Street Capital Management LLC | 0 | $0 | 0.00% | −49,073−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −43,562−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −41,194−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −39,031−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −37,915−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −24,745−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −18,551−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −17,313−100.0% | Sold out |
| Rothschild Investment Corp | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −14,590−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,594−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −12,744−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −11,735−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −11,529−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −11,064−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −10,949−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −6,889−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −4,190−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −4,190−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,654−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −594−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −281−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Institutional & Family Asset Management, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |